Merck Sees 5% Revenue Growth in Q2 2026 Amid Diverse Asset Classes

Merck reported a 5% revenue growth in Q2 2026, according to Pluang. The financial application's data showed that Merck's revenue increased during this period. This growth is a significant milestone for the company, which operates in various asset classes.

The company provides access to US Stocks, ETFs, and Options through PT PG Berjangka as a Derivatives Broker licensed by the Financial Services Authority of Indonesia (OJK). Indonesian Stocks are facilitated by PT Sarana Santosa Sejati, while Crypto Assets and Digital Financial Asset Derivatives (Crypto Futures) are handled by PT Bumi Santosa Cemerlang.

Mutual Funds are facilitated by PT Sarana Santosa Sejati as a Mutual Fund Securities Selling Agent, and Gold is provided through PT Pluang Emas Sejahtera. All investments involve risks, and past performance does not guarantee future results.